Drug shelf life testing

Ended Definitive Contract Awarded Last action

Contract number
HHSN261201800003C
Awardee
Awarding agency
Obligated
$1,658,743

Award facts

Opportunity
Contract value 100% obligated
$1,658,742.83 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Full and Open Competition · 4 offers Negotiated Proposal / Quote
Pricing
Cost Plus Fixed Fee
Place of performance
Kansas City, MO 64110, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Supplemental Agreement for work within scope P00020 -$170,562
Supplemental Agreement for work within scope P00019 -$82
Funding Only Action P00018 -$55,000
Supplemental Agreement for work within scope P00017 · Drug shelf life testing period of performance 02/01/2023 - 07/31/2023 $100,000
Other Administrative Action P00016 $100,000
Funding Only Action P00015 $98,000
Other Administrative Action P00014 $0
Funding Only Action P00013 $110,000
Exercise an Option P00012 -$87,858
Funding Only Action P00011 · Drug shelf life testing period of performance 01/31/2021 - 09/30/2021 (option year #3) $20,797
Funding Only Action P00010 · Drug shelf life testing period of performance 10/31/2021 - 01/31/2022 (option year #3) $200,000
Exercise an Option P00009 · Drug shelf life testing period of performance 08/01/2020 - 01/31/2022 (option year #3) $230,000
Exercise an Option P00008 · Drug shelf life testing period of performance 08/01/2020 - 01/31/2021 (option year #2; $200,000) $200,000
Exercise an Option P00007 · Drug shelf life testing period of performance 02/01/2018 - 01/31/2021 (option year #2; $200,000) $200,000
Funding Only Action P00006 $50,000
Funding Only Action P00005 · Drug shelf life testing period of performance 02/01/2018 - 01/31/2020 $13,833
Exercise an Option P00004 $291,115
Funding Only Action P00003 $20,000
Funding Only Action P00002 $38,500
Other Administrative Action P00001 · The purpose of this modification is to add government furnished equipment from HHSN261201300007C to HHSN261201800003C. The piece of equipment being added is… $0
Original award $300,000
Show all 21

About this award

Written by GovTribe AI ·

This is a Cost Plus Fixed Fee contract awarded by the National Cancer Institute to Mriglobal, a 501(c)(3) not-for-profit research organization based in Kansas City, Missouri. The contract, valued at $1,658,742.83, is for drug shelf life testing services. The contract does not have a set-aside designation. Mriglobal has significant experience as a prime contractor for the federal government, holding multiple Indefinite Delivery Vehicles (IDVs) with various agencies such as the National Institute of Allergy and Infectious Diseases, the Office of the Assistant Secretary for Preparedness and Response, and the National Center for Advancing Translational Sciences. These IDVs enable Mriglobal to provide specialized scientific and technical services across a wide range of critical research and development programs, including medical countermeasure development, biosafety testing, and infectious disease research.

Quick answers

Who was awarded contract HHSN261201800003C?

HHSN261201800003C was awarded to Mriglobal by National Cancer Institute (National Institutes of Health) on February 1, 2018.

How much is contract HHSN261201800003C worth?

The government has obligated $1,658,743 on HHSN261201800003C.

Was contract HHSN261201800003C competed?

The extent of competition for HHSN261201800003C was full and open competition. The government received 4 offers.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award
Try for free Login